Banimmo SA (EBR:BANI)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	37	32	43	45	42	31
Market Cap Growth	-25.13%	-25.13%	-4.98%	6.92%	38.23%	-20.93%
Enterprise Value	120	100	94	87	126	89
Last Close Price	3.26	2.86	3.82	4.02	3.76	2.72
PE Ratio	15.69	13.77	-	13.56	1.69	-
PS Ratio	5.00	4.39	6.84	8.28	0.52	9.82
PB Ratio	0.52	0.46	0.64	0.62	0.61	0.69
P/OCF Ratio	-	-	-	-	0.61	-
EV/Sales Ratio	16.34	13.68	14.93	16.00	1.54	28.59
EV/EBITDA Ratio	28.13	26.17	-	753.48	5.99	60.34
EV/EBIT Ratio	31.46	26.34	-	1942.30	6.01	63.75
Debt / Equity Ratio	1.21	1.21	1.12	0.92	1.36	1.93
Debt / EBITDA Ratio	19.89	19.89	-	122.96	4.36	45.31
Asset Turnover	0.05	0.05	0.04	0.03	0.49	0.02
Inventory Turnover	-	-	0.12	0.05	1.22	-
Quick Ratio	0.18	0.18	2.12	1.01	1.51	2.10
Current Ratio	1.06	1.06	4.83	2.11	2.09	7.08
Return on Equity (ROE)	4.30%	4.30%	-9.21%	2.13%	47.12%	-2.77%
Return on Assets (ROA)	1.47%	1.47%	-0.86%	0.02%	7.76%	0.64%
Return on Capital (ROIC)	1.60%	1.60%	-0.94%	0.02%	8.95%	0.70%
Earnings Yield	6.37%	7.26%	-15.86%	7.37%	59.11%	-5.37%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.